Novo Nordisk Cuts Wegovy Prices with New Subscription Plan to Boost U.S. Access
Novo Nordisk has introduced a discounted subscription plan for its blockbuster obesity drug Wegovy in the United States, aiming to expand access for patients paying out of pocket and regain momentum against rival Eli...